Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early versus standard-timing Botox for spastic equinus in children with cerebral palsy
ACTRN12607000484448Phase 3Active, not recruiting
- Sponsor
- Sarah Love
- Start
- Oct 2002
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of botulinum toxin type A in cerebral palsy (CP) and Muscle spasm (2 arms), sponsored by Sarah Love. Primary endpoints: Quality of gait, Dynamic calf muscle spasticity and 1 more. Started Oct 2002; status: active, not recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
cerebral palsy (CP)Muscle spasm
Beyond the preview
Go deeper on ACTRN12607000484448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000484448.